Printer Friendly
The Free Library
14,574,623 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

GeneThera Grants First Right of Refusal to Ante-Mortem Animal Disease Diagnostics.


WHEAT RIDGE, Colo. -- GeneThera, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:GTHA) has granted Beckman Coulter, Inc. (NYSE NYSE

See: New York Stock Exchange
:BEC) the first right of refusal to license GeneThera's patented technology for the development of ante-mortem animal diagnostic tests. This is part of a collaboration reached between the two companies allowing GeneThera and Beckman Coulter to share data pertaining to the validation of GeneThera's live animal blood tests for several animal diseases.

Dr. Antonio Milici, M.D., Ph.D. commented, "This is a significant milestone for GeneThera. Beckman Coulter is one of the world's leading manufacturers of biomedical testing systems, tests and supplies. Our collaboration will unite the expertise of Beckman Coulter with the cutting edge technology of GeneThera."

"We are looking forward to working with GeneThera to identify commercial applications of their technology," stated Chris Neary, General Manager, Prion prion (prī`ŏn), infectious agent thought to cause a group of diseases known as

prion diseases or transmissible spongiform encephalopathies.
 Business Center, Beckman Coulter, Inc.

About GeneThera:

GeneThera, Inc. is a molecular biotechnology company located in Wheat Ridge, CO. The Company provides genetic diagnostic solutions for the veterinary and agricultural industries with future plans to include the health-care industry. The Company's proprietary diagnostic solution is based on a genetic expression assay, GEA(TM), a protocol designed to function on a highly automated Fluorogenic PCR PCR polymerase chain reaction.

PCR
abbr.
polymerase chain reaction


Polymerase chain reaction (PCR) 
 platform. This platform enables GeneThera to offer tests that are presently not available from other technologies. The GEA is designed for a host of individual diseases, the current priority being Chronic Wasting Disease Noun 1. chronic wasting disease - a wildlife disease (akin to bovine spongiform encephalitis) that affects deer and elk
animal disease - a disease that typically does not affect human beings
, a disease affecting elk and deer in North America; E.Coli 0157:H7 and Johne's Disease, diseases affecting cattle worldwide. Future plans include all infectious disease potentially affecting domesticated do·mes·ti·cate  
tr.v. do·mes·ti·cat·ed, do·mes·ti·cat·ing, do·mes·ti·cates
1. To cause to feel comfortable at home; make domestic.

2. To adopt or make fit for domestic use or life.

3.
a.
 livestock as well wildlife intended for human consumption, particular priority being given to Mad Cow and Foot & Mouth diseases in cattle.

"Safe Harbor" Statement: Certain statements in this release are "forward-looking" statements as defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Such statements are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the Company's ability to meet the terms and conditions required to obtain its project financing, risks and delays associated with product development, risk of market acceptance of new products, risk of technology or product obsolescence ob·so·les·cent  
adj.
1. Being in the process of passing out of use or usefulness; becoming obsolete.

2. Biology Gradually disappearing; imperfectly or only slightly developed.
, competitive risks, reliance on development partners and the need for additional capital.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 11, 2005
Words:390
Previous Article:GARDA WORLD AWARDED EDMONTON & FORT MCMURRAY AIRPORTS.
Next Article:Optoma Ships Highly Anticipated MovieTime Digital DVD Projector; MovieTime Digital Projector Features Built-in DVD Player and Integrated Speakers for...
Topics:



Related Articles
Symmetrical Erosive Peripheral Polyarthritis in the Late Archaic Period of Alabama.
PHOTOCURE SIGNS NEW PACT WITH NORWEGIAN RADIUM HOSPITAL.
Antimicrobial growth promoters and Salmonella spp., Campylobacter spp. in poultry and swine, Denmark. (Dispatches).
IMUGENE RECEPTOR MIMIC TECHNOLOGY PATENT GRANTED IN U.S.
Travel-associated rabies in Austrian man.(DISPATCHES)
Confronting zoonoses, linking human and veterinary medicine.
BERLEX JOINS STRATEGIC DIAGNOSTICS IN ANTIBODY EFFORT.
Emergence of Arctic-like rabies lineage in India.(RESEARCH)
Fatal reactive hemophagocytosis related to disseminated histoplasmosis with endocarditis: an unusual case diagnosed at autopsy.(Clinical report)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles